# Risankizumab (Genetical Recombination) S.C. Injection (スキリージ皮下注３６０ｍｇオートドーザー)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 3999450G4027). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 3999450G4027
- **Product name (Japanese):** スキリージ皮下注３６０ｍｇオートドーザー
- **English title:** Risankizumab (Genetical Recombination) S.C. Injection
- **Active ingredient:** リサンキズマブ（遺伝子組換え）
- **Active ingredient (INN):** Risankizumab (Genetical Recombination)
- **Strength / unit:** ３６０ｍｇ２．４ｍＬ１キット
- **Route:** Injection (注射薬)
- **Therapeutic category:** 39 Other metabolic agents (その他の代謝性医薬品) › 399 Other metabolic agents (n.e.c.) (他に分類されない代謝性医薬品)
- **Manufacturer:** AbbVie (アッヴィ)
- **NHI price (reference only):** JPY 446462 per ３６０ｍｇ２．４ｍＬ１キット
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/3999450G4027
- **JSON:** https://www.nifujipharma.com/api/drugs/3999450G4027

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Risankizumab%20(Genetical%20Recombination)%20S.C.%20Injection%20(%E3%82%B9%E3%82%AD%E3%83%AA%E3%83%BC%E3%82%B8%E7%9A%AE%E4%B8%8B%E6%B3%A8%EF%BC%93%EF%BC%96%EF%BC%90%EF%BD%8D%EF%BD%87%E3%82%AA%E3%83%BC%E3%83%88%E3%83%89%E3%83%BC%E3%82%B6%E3%83%BC)%20%2F%20YJ%203999450G4027#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Risankizumab (Genetical Recombination)

- [Risankizumab (Genetical Recombination) I.V. Infusion 600mg (スキリージ点滴静注６００ｍｇ)](https://www.nifujipharma.com/drugs/3999450A1025) — ６００ｍｇ１０ｍＬ１瓶, AbbVie
- [Risankizumab (Genetical Recombination) S.C. Injection 75mg Syringe 0.83mL (スキリージ皮下注７５ｍｇシリンジ０．８３ｍＬ)](https://www.nifujipharma.com/drugs/3999450G1028) — ７５ｍｇ０．８３ｍＬ１筒, AbbVie
- [Risankizumab (Genetical Recombination) S.C. Injection 150mg Syringe 1mL (スキリージ皮下注１５０ｍｇシリンジ１ｍＬ)](https://www.nifujipharma.com/drugs/3999450G2024) — １５０ｍｇ１ｍＬ１筒, AbbVie
- [Risankizumab (Genetical Recombination) S.C. Injection 150mg Pen 1mL (スキリージ皮下注１５０ｍｇペン１ｍＬ)](https://www.nifujipharma.com/drugs/3999450G3020) — １５０ｍｇ１ｍＬ１キット, AbbVie
- [Risankizumab (Genetical Recombination) S.C. Injection (スキリージ皮下注１８０ｍｇオートドーザー)](https://www.nifujipharma.com/drugs/3999450G5023) — １８０ｍｇ１．２ｍＬ１キット, AbbVie